Georgette Le Thuillier

Title: Georgette Le Thuillier: Innovator in Synthetic Peptide Research

Introduction

Georgette Le Thuillier is a notable inventor based in Morangis, France. She has made significant contributions to the field of synthetic peptides, particularly in relation to cholera and infectious gastro-enteritis. With a total of 2 patents, her work has the potential to impact medical treatments and diagnostics.

Latest Patents

Le Thuillier's latest patents focus on novel synthetic peptides and their applications. One of her inventions provides a synthetic peptide that reproduces at least five of the eleven amino acids common to the gamma chain of sub-unit A of cholera toxin and the gamma chain of LT toxin of Escherichia coli. This synthetic peptide is preferably a pentadecapeptide, synthesized through a step-by-step construction process starting from the C terminal end of the peptide chain. Additionally, her patents disclose a novel medicament for treating cholera and infectious gastro-enteritis, which includes this synthetic peptide as an active constituent. Furthermore, a diagnostic agent for cholera and/or infectious gastro-enteritis is also described, comprising a sequence of nucleotides corresponding to the minimum five amino acids of the synthetic peptide.

Career Highlights

Georgette Le Thuillier is affiliated with the prestigious Institut Pasteur, where she conducts her research. Her work has garnered attention for its innovative approach to addressing significant health issues related to cholera and gastro-enteritis.

Collaborations

Le Thuillier has collaborated with notable colleagues such as Odile Siffert and Patrice Allard, contributing to the advancement of research in her field.

Conclusion

Georgette Le Thuillier's contributions to synthetic peptide research are noteworthy and have the potential to lead to significant advancements in medical treatments and diagnostics. Her innovative work continues to inspire future research in the field.